A blood test can predict the risk of dementia in women up to 25 years before symptoms appear, researchers say.Experts in the US found that higher levels of a protein called p-tau217 – which is linked ...

UC San Diego researchers found a blood-based biomarker can predict a woman's risk of developing dementia as many as 25 years before symptoms appear, according to a paper published Tuesday.

Experts in the US found that higher levels of a protein called p-tau217 were an accurate predictor of people developing cognitive problems and dementia.

New research suggests that an existing blood test may help to determine when someone is likely to develop Alzheimer's disease ...

A long-term study of 2,766 women in the Women’s Health Initiative Memory Study found that higher baseline plasma p-tau217 levels were associated with a greater risk of developing mild cognitive ...

Add Yahoo as a preferred source to see more of our stories on Google. From CBC to CMP and beyond, blood test panels provide essential information to health practitioners. angelp/iStock via Getty ...

Scientists develop a blood test that detects Alzheimer’s by measuring protein structural changes rather than protein quantity.

Blood test results can be overwhelming to digest, complete with medical jargon and numerical values that may not mean much without an accompanying explanation. But to take charge of your health and ...

A protein lurking around in the blood can help with the accurate diagnosis of Alzheimer's disease. In a recent study, researchers from Spain investigated how blood-based biomarkers, such as a protein ...

Women with higher levels of p-tau217, a blood protein, were twice as likely to eventually develop dementia or mild cognitive impairment.

Scientists found that a blood protein called p tau217 may reveal dementia risk up to 25 years before symptoms appear.